Role of D1 and D2 receptors in the regulation of voluntary movements

Bulletin of Experimental Biology and Medicine

Volumn 146, Issue 1, 2008, Pages 14-17

  Korchounov, A M ^a  

^a Center for Locomotor Disorders   (Germany)

Author keywords

Dopamine; Dopamine receptor; Model; Muscle fiber; Regulation of movements

Indexed keywords

CABERGOLINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR CORTEX; MOTOR CORTEX EXCITABILITY; MUSCLE ACTION POTENTIAL; MUSCLE CONTRACTILITY; MUSCLE TONE; NORMAL HUMAN; REGULATORY MECHANISM; REST; TRANSCRANIAL MAGNETIC STIMULATION; VOLUNTARY MOVEMENT;

ADULT; BRAIN; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HUMANS; MALE; MOVEMENT; MUSCLE CONTRACTION; MUSCLE TONUS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; YOUNG ADULT;

EID: 58049175858     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0197-0     Document Type: Article

References (18)

1. O. Aizman, H. Brismar, P. Uhlen, et al., Nat. Neurosci., 3, No. 3, 226-230 (2000).
2. S. Callier, M. Snapyan, S. Le Crom, et al., Biol. Cell, 95, No. 7, 489-502 (2003).
3. R. Cantello, R. Tarletti, and C. Civardi, Brain Res. Brain Res. Rev., 38, No. 3, 309-327 (2002).
4. D. Cunic, L. Roshan, F. I. Khan, et al., Neurology, 58, No. 11, 1665-1672 (2002).
5. J. Dauper, T. Peschel, C. Schrader, et al., Ibid., 59, No. 5, 700-706 (2002).
6. M. R. DeLong, Trends Neurosci., 13, No. 7, 281-285 (1990).
7. W. K. Durfee and K. I. Palmer, IEEE Trans. Biomed. Eng., 41, No. 3, 205-216 (1994).
8. P. Foley, M. Gerlach, K. L. Double, and P. Riederer, J. Neural. Transm., 111, Nos. 10-11, 1375-1446 (2004).
9. F. Gonon, J. Neurosci., 17, No. 15, 5972-5978 (1997).
10. S. M. Hersch, B. J. Ciliax, C. A. Gutekunst, et al., Ibid., 15, No. 7, 5222-5237 (1995).
11. J. C. Martin, N. A. Brown, F. C. Anderson, and W. W. Spirduso, J. Biomech., 33, No. 8, 969-974 (2000).
12. W. H. Oertel and N. P. Quinn, Neurological Disorders: Course and Treatment, Eds. T. Brandt et al., San Diego (1995), pp. 715-772.
13. W. Schultz, L. Tremblay, and J. R. Hollerman, Neuropharmacology, 37, Nos. 4-5, 421-429 (1998).
14. S. C. Sealfon and C. W. Olanow, Trends Neuro. Sci., 23, Suppl. 10, S34-S40 (2000).
15. R. S. Staron, Can. J. Appl. Physiol., 22, No. 4, 307-327 (1997).
16. E. Svensson, M. A. Wikstrom, R. H. Hill, and S. Grillner, Eur. J. Neurosci., 17, No. 3, 447-454 (2003).
17. T. Wichmann and M. R. DeLong, Curr. Opin. Neurobiol., 6, No. 6, 751-758 (1996).
18. P. Zheng, X. X. Zhang, B. S. Bunney, and W. X. Shi, Neuroscience, 91, No. 2, 527-535 (1999).